We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

MorphoSys to Present Data on Proprietary Programs at ASCO Annual Meeting

News   May 26, 2015

 
MorphoSys to Present Data on Proprietary Programs at ASCO Annual Meeting
 
 
Advertisement
 

RELATED ARTICLES

mRNA Delivery System Produces Therapeutic Protein in Rat Brains

News

Researchers from Tokyo Medical and Dental University (TMDU) demonstrate an mRNA delivery system that effectively produces BDNF protein in rat brain to protect neurons from ischemia.

READ MORE

Phase 1 Study of Novel Oral Antiviral Against SARS-CoV-2 Initiated

News

Pfizer's oral antiviral clinical candidate PF-07321332, a SARS-CoV2-3CL protease inhibitor, is progressing to Phase 1 testing following preclinical testing demonstrating potent in vitro anti-viral activity against SARS-CoV-2.

READ MORE

New “Weapon” Against Cancer Enters Clinical Trials

News

Scientists are aiming to validate an innovative radiotherapy as part of a safe, more effective and potentially less costly treatment for bladder cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Biopharma

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE